Cabinet approves foreign investment of up to Rs 9,589 crore in Suven Pharma

The Cabinet Committee on Economic Affairs has approved foreign investment of up to Rs 9,589 crore in Suven Pharmaceuticals by Cyprus-based Berhyanda Limited. This Cabinet approval allows Berhyanda to acquire up to 76.1% equity shares of Suven Pharmaceuticals, potentially increasing the aggregate foreign investment in the company up to 90.1%.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news